Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Outcomes Research Consortium, Cleveland, OH, USA.
J Clin Monit Comput. 2022 Apr;36(2):341-347. doi: 10.1007/s10877-021-00653-9. Epub 2021 Feb 1.
It remains unclear whether reduced myocardial contractility, venous dilation with decreased venous return, or arterial dilation with reduced systemic vascular resistance contribute most to hypotension after induction of general anesthesia. We sought to assess the relative contribution of various hemodynamic mechanisms to hypotension after induction of general anesthesia with sufentanil, propofol, and rocuronium. In this prospective observational study, we continuously recorded hemodynamic variables during anesthetic induction using a finger-cuff method in 92 non-cardiac surgery patients. After sufentanil administration, there was no clinically important change in arterial pressure, but heart rate increased from baseline by 11 (99.89% confidence interval: 7 to 16) bpm (P < 0.001). After administration of propofol, mean arterial pressure decreased by 23 (17 to 28) mmHg and systemic vascular resistance index decreased by 565 (419 to 712) dynscm*m (P values < 0.001). Mean arterial pressure was < 65 mmHg in 27 patients (29%). After propofol administration, heart rate returned to baseline, and stroke volume index and cardiac index remained stable. After tracheal intubation, there were no clinically important differences compared to baseline in heart rate, stroke volume index, and cardiac index, but arterial pressure and systemic vascular resistance index remained markedly decreased. Anesthetic induction with sufentanil, propofol, and rocuronium reduced arterial pressure and systemic vascular resistance index. Heart rate, stroke volume index, and cardiac index remained stable. Post-induction hypotension therefore appears to result from arterial dilation with reduced systemic vascular resistance rather than venous dilation or reduced myocardial contractility.
在全身麻醉诱导后,心肌收缩力降低、静脉扩张伴静脉回流减少、动脉扩张伴全身血管阻力降低,哪种机制对低血压的贡献最大尚不清楚。我们旨在评估舒芬太尼、丙泊酚和罗库溴铵全身麻醉诱导后各种血流动力学机制对低血压的相对贡献。在这项前瞻性观察性研究中,我们连续记录了 92 例非心脏手术患者在麻醉诱导期间使用手指袖带法的血流动力学变量。舒芬太尼给药后,动脉压无临床重要变化,但心率从基线增加了 11 次/分(99.89%置信区间:7 至 16)(P<0.001)。丙泊酚给药后,平均动脉压下降 23mmHg(17 至 28mmHg),全身血管阻力指数下降 565(419 至 712)dynscm*m(P 值均<0.001)。27 例患者(29%)的平均动脉压<65mmHg。丙泊酚给药后,心率恢复至基线,而每搏量指数和心指数保持稳定。气管插管后,与基线相比,心率、每搏量指数和心指数无临床重要差异,但动脉压和全身血管阻力指数仍明显降低。舒芬太尼、丙泊酚和罗库溴铵全身麻醉诱导降低了动脉压和全身血管阻力指数。心率、每搏量指数和心指数保持稳定。因此,诱导后低血压似乎是由于动脉扩张伴全身血管阻力降低所致,而不是静脉扩张或心肌收缩力降低。